Breast Cancer Research and Treatment Oncology

Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B)

Meiko Nishimura, Takahiro Kogawa, Keiji Sugiyama, Yukinori Ozaki, Yuko Tanabe, Chikako Funasaka, Sasagu Kurozumi, Akiyo Yoshimura, Tsutomu Iwasa, Hitomi Sakai, Mitsunori Morita, Satomi Watanabe, Takaaki Fujii, Mitsugu Yamamoto, Yasushi Tsuji, Mitsuo Terada, Takayo Ota, Shinya Tokunaga, Mototsugu Shimokawa, Toshimi Takano
Springer Nature · 2026-07-01 · DOI 10.1007/s10549-026-08031-2

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →